Tianqi Nie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tianqi Nie has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jun Wu
Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Nansha, Guangzhou 511400, China
5 shared publications - Yiqun Wu
Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, China
2 shared publications - Yuenong Jiao
Department of Otorhinolaryngology Head and Neck Surgery, Guangzhou Twelfth People's Hospital (The Affiliated Twelfth People's Hospital of Guangzhou Medical University), Guangzhou Medical University, Guangzhou 510620, China; Institute of Otorhinolaryngology, Head and Neck Surgery, Guangzhou Medical University, Guangzhou 510620, China
2 shared publications - Chunlin Huang
School of Biomedical Engineering, Sun Yat-Sen University, Shenzhen 518107, China
1 shared publication - Cuiqing Huang
The Guangzhou Key Laboratory of Molecular and Functional Imaging For Clinical Translation Department of Radiology and Nuclear Medicine The First Affiliated Hospital of Jinan University Guangzhou China
1 shared publication - Duo Wang
The Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China
1 shared publication
Latest Publications
- 24 January 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 212, 103-123
Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics
- 24 January 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 212, 103-123
Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics
- 2 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 327 (Pt 1) , 147372
Zinc ions coordinated carboxymethyl chitosan hydrogel doped with ellagic acid for accelerative diabetic wound healing
- 2 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 327 (Pt 1) , 147372
Zinc ions coordinated carboxymethyl chitosan hydrogel doped with ellagic acid for accelerative diabetic wound healing
- 18 June 2025
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (1) , 53-64
Auricular repair: symphony between scaffolds and stem cells
- 18 June 2025
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (1) , 53-64
Auricular repair: symphony between scaffolds and stem cells
- 30 November 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 284 (Pt 2) , 138233
Muco-adhesive chitosan-coated polyphenol nanoparticle for treatment of infectious acute pneumonia through sustained pulmonary delivery of polymyxin B
- 30 November 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 284 (Pt 2) , 138233
Muco-adhesive chitosan-coated polyphenol nanoparticle for treatment of infectious acute pneumonia through sustained pulmonary delivery of polymyxin B
- Open Access
- 19 November 2024
- Published by MDPI AG in Preprints.org
Sestrin2 Enhances Mitochondrial Function to Alleviate Age-Related Hearing Loss
Mitochondrial dysfunction and oxidative stress are key contributors to age-related hearing loss (ARHL). Sestrin2, a stress-inducible antioxidant protein, decreases with age, impacting various age-related diseases; however, its role in ARHL remains unclear. In this study, we initially assessed hearing in 8-week-old mice, followed by adeno-associated virus-mediated transfection of Sestrin2 into the posterior semicircular canal. At 26 weeks, hearing was reassessed, and cochlear samples were analysed. Immunofluorescence staining revealed Sestrin2 localization and mitophagy marker PINK1 expression, and TUNEL staining was used to assess hair cell apoptosis rate. We also measured mitochondrial membrane potential and examined AMPKα, mTOR, PINK1, Parkin, and Sestrin2 protein levels. Results showed reduced Sestrin2 in ARHL-affected hair cells, leading to mitochondrial dysfunction and increased apoptosis. Sestrin2 overexpression enhanced mitochondrial membrane potential, ATP levels, and mitochondrial function, delaying hair cell ageing and apoptosis and improving hearing. Furthermore, AMPK activation inhibited mTOR to promote mitophagy as the cells aged, whereas Sestrin2 overexpression inhibited this pathway, directly protecting hair cells. These findings highlight Sestrin2’s critical role in auditory health and its potential as a therapeutic target for delaying ARHL.
- 19 November 2024
- Published by MDPI AG in Preprints.org
Open AccessSestrin2 Enhances Mitochondrial Function to Alleviate Age-Related Hearing Loss
Mitochondrial dysfunction and oxidative stress are key contributors to age-related hearing loss (ARHL). Sestrin2, a stress-inducible antioxidant protein, decreases with age, impacting various age-related diseases; however, its role in ARHL remains unclear. In this study, we initially assessed hearing in 8-week-old mice, followed by adeno-associated virus-mediated transfection of Sestrin2 into the posterior semicircular canal. At 26 weeks, hearing was reassessed, and cochlear samples were analysed. Immunofluorescence staining revealed Sestrin2 localization and mitophagy marker PINK1 expression, and TUNEL staining was used to assess hair cell apoptosis rate. We also measured mitochondrial membrane potential and examined AMPKα, mTOR, PINK1, Parkin, and Sestrin2 protein levels. Results showed reduced Sestrin2 in ARHL-affected hair cells, leading to mitochondrial dysfunction and increased apoptosis. Sestrin2 overexpression enhanced mitochondrial membrane potential, ATP levels, and mitochondrial function, delaying hair cell ageing and apoptosis and improving hearing. Furthermore, AMPK activation inhibited mTOR to promote mitophagy as the cells aged, whereas Sestrin2 overexpression inhibited this pathway, directly protecting hair cells. These findings highlight Sestrin2’s critical role in auditory health and its potential as a therapeutic target for delaying ARHL.
- Open Access
- 11 April 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1207
Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
Abnormal tumor vasculature and a hypoxic tumor microenvironment (TME) limit the effectiveness of conventional cancer treatment. Recent studies have shown that antivascular strategies that focus on antagonizing the hypoxic TME and promoting vessel normalization effectively synergize to increase the antitumor efficacy of conventional therapeutic regimens. By integrating multiple therapeutic agents, well-designed nanomaterials exhibit great advantages in achieving higher drug delivery efficiency and can be used as multimodal therapy with reduced systemic toxicity. In this review, strategies for the nanomaterial-based administration of antivascular therapy combined with other common tumor treatments, including immunotherapy, chemotherapy, phototherapy, radiotherapy, and interventional therapy, are summarized. In particular, the administration of intravascular therapy and other therapies with the use of versatile nanodrugs is also described. This review provides a reference for the development of multifunctional nanotheranostic platforms for effective antivascular therapy in combined anticancer treatments.
- 11 April 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1207
Open AccessNanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
Abnormal tumor vasculature and a hypoxic tumor microenvironment (TME) limit the effectiveness of conventional cancer treatment. Recent studies have shown that antivascular strategies that focus on antagonizing the hypoxic TME and promoting vessel normalization effectively synergize to increase the antitumor efficacy of conventional therapeutic regimens. By integrating multiple therapeutic agents, well-designed nanomaterials exhibit great advantages in achieving higher drug delivery efficiency and can be used as multimodal therapy with reduced systemic toxicity. In this review, strategies for the nanomaterial-based administration of antivascular therapy combined with other common tumor treatments, including immunotherapy, chemotherapy, phototherapy, radiotherapy, and interventional therapy, are summarized. In particular, the administration of intravascular therapy and other therapies with the use of versatile nanodrugs is also described. This review provides a reference for the development of multifunctional nanotheranostic platforms for effective antivascular therapy in combined anticancer treatments.
- 14 December 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 229, 123-135
Tomato based gelatin methacryloyl hydrogel as an effective natural and low-cost scaffold for accelerative wound healing
- 14 December 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 229, 123-135
Tomato based gelatin methacryloyl hydrogel as an effective natural and low-cost scaffold for accelerative wound healing